US FDA Denies Approval of MDMA as PTSD Treatment
FDA Rejects MDMA The FDA in the United States has rejected the use of MDMA, also referred to as ecstasy or molly, as a treatment for post-traumatic stress disorder (PTSD). After the agency examined the psychedelic medication created by Lykos Therapeutics, which was meant to be used in conjunction with talk therapy to treat the...
Read more